Glioma: experimental models and reality

K Lenting, R Verhaak, M Ter Laan, P Wesseling… - Acta …, 2017 - Springer
In theory, in vitro and in vivo models for human gliomas have great potential to not only
enhance our understanding of glioma biology, but also to facilitate the development of novel …

Zebrafish: speeding up the cancer drug discovery process

P Letrado, I de Miguel, I Lamberto, R Díez-Martínez… - Cancer research, 2018 - AACR
Zebrafish (Danio rerio) is an ideal in vivo model to study a wide variety of human cancer
types. In this review, we provide a comprehensive overview of zebrafish in the cancer drug …

Benefits of zebrafish xenograft models in cancer research

X Chen, Y Li, T Yao, R Jia - Frontiers in Cell and Developmental …, 2021 - frontiersin.org
As a promising in vivo tool for cancer research, zebrafish have been widely applied in
various tumor studies. The zebrafish xenograft model is a low-cost, high-throughput tool for …

Management and potentialities of primary cancer cultures in preclinical and translational studies

G Miserocchi, L Mercatali, C Liverani, A De Vita… - Journal of translational …, 2017 - Springer
The use of patient-derived primary cell cultures in cancer preclinical assays has increased in
recent years. The management of resected tumor tissue remains complex and a number of …

Dietary flavonoids luteolin and quercetin inhibit migration and invasion of squamous carcinoma through reduction of Src/Stat3/S100A7 signaling

JJ Fan, WH Hsu, KH Lee, KC Chen, CW Lin, YLA Lee… - Antioxidants, 2019 - mdpi.com
Flavonoids are well-known antioxidants and have shown the ability to prevent tumor
formation and recurrence. Especially in dietary flavonoids, they have provided convenience …

Zebrafish: a new companion for translational research in oncology

J Barriuso, R Nagaraju, A Hurlstone - Clinical Cancer Research, 2015 - AACR
In an era of high-throughput “omic” technologies, the unprecedented amount of data that can
be generated presents a significant opportunity but simultaneously an even greater …

Precision medicine in head and neck cancers: genomic and preclinical approaches

G Miserocchi, C Spadazzi, S Calpona… - Journal of Personalized …, 2022 - mdpi.com
Head and neck cancers (HNCs) represent the sixth most widespread malignancy worldwide.
Surgery, radiotherapy, chemotherapeutic and immunotherapeutic drugs represent the main …

Modeling cancer using zebrafish xenografts: drawbacks for mimicking the human microenvironment

P Cabezas-Sáinz, A Pensado-López, B Sáinz Jr… - Cells, 2020 - mdpi.com
The first steps towards establishing xenografts in zebrafish embryos were performed by Lee
et al., 2005 and Haldi et al., 2006, paving the way for studying human cancers using this …

Rethinking cancer: current challenges and opportunities in cancer research

R Cagan, P Meyer - Disease models & mechanisms, 2017 - journals.biologists.com
Cancer therapeutics currently have the lowest clinical trial success rate of all major
diseases. Partly as a result of the paucity of successful anti-cancer drugs, cancer will soon …

Understanding the uptake of nanomedicines at different stages of brain cancer using a modular nanocarrier platform and precision bispecific antibodies

ZH Houston, J Bunt, KS Chen, S Puttick… - ACS central …, 2020 - ACS Publications
Increasing accumulation and retention of nanomedicines within tumor tissue is a significant
challenge, particularly in the case of brain tumors where access to the tumor through the …